Overview

A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets

Status:
Not yet recruiting
Trial end date:
2022-07-04
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to compare the pharmacokinetics (PK) of sotorasib administered orally as 1 tablet under fasted conditions to sotorasib administered orally as 2 tablets under fasted conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Amgen